HERON ELAINE J
SEC Form 4 insider trading activity
HERON ELAINE J has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VXRT, PVLA, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 18, 2026.
On the most recent filing, HERON ELAINE J is listed as Director at PALVELLA THERAPEUTICS, INC. Inside the rolling window, HERON ELAINE J reported 2 open-market purchases totaling $316K in PVLA and VXRT and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,400 PVLA shares on Feb 27, 2026, worth $300K.
Companies traded
Other insiders at VXRT
Insider Buying
$316K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HERON ELAINE J made?
HERON ELAINE J has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VXRT, PVLA since 2025.
Which companies does HERON ELAINE J trade?
HERON ELAINE J has filed SEC Form 4 disclosures for 2 companies, including VXRT, PVLA.
When was HERON ELAINE J's most recent SEC Form 4 filing?
HERON ELAINE J's most recent SEC Form 4 filing on Tracefour is dated Jul 18, 2026.
What is HERON ELAINE J's total buy and sell value in the current window?
Inside the rolling retention window, HERON ELAINE J bought $316K and sold $0 based on SEC Form 4 filings.
What was HERON ELAINE J's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,400 PVLA shares on 2026-02-27, worth $300K, per SEC Form 4 filings.